March 04, 2026

The Promise of Artificial Intelligence to Aid in Systematic Reviews: An Examination of Scopus AI

The integration of AI in systematic reviews could revolutionize oncology practice, as highlighted by recent studies and tools like Scopus AI.

JADPRO

March 04, 2026

Innovations Shaping Women’s Cancer Care in 2026

As we move through 2026, new technologies and refined surgical techniques are transforming outcomes for women facing cancer diagnoses.

Baptist Health South Florida

March 03, 2026

Kyaw Aung, M.B.B.S., Ph.D., Joins Baptist Health Miami Cancer Institute

Medical oncologist Kyaw Aung, M.B.B.S., Ph.D., has joined Baptist Health Miami Cancer Institute. He specializes in gastrointestinal cancers, particularly pancreatic cancer.

Baptist Health South Florida

February 27, 2026

Sequencing Therapies in Non-Hodgkin Lymphomas

Guiding oncology practitioners on integrating advanced therapies for B-cell non-Hodgkin lymphomas, JADPRO Live 2025 featured critical insights from F. Brianne Buchanan and Tatjana Grgic.

JADPRO

February 27, 2026

Boca Raton Regional Hospital Foundation Honors Donors at Proton Therapy Center

The Boca Raton Regional Hospital Foundation celebrated with donors the upcoming addition of proton therapy at the Eugene M. & Christine E. Lynn Cancer Institute, at the Harvey & Phyllis Sandler Pavilion at Boca Raton Regional Hospital, part of Baptist Health.  

Baptist Health South Florida

February 27, 2026

Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer

Explore the latest insights on treating metastatic triple-positive breast cancer, emphasizing multimodal therapy and adverse event management, as discussed by oncology experts at JADPRO Live 2025.

JADPRO

February 25, 2026

Can Induction Improve Survival in High-Risk, Locally Advanced Cervical Cancer?

Rates of overall and progression-free survival for locally advanced cervical cancer have risen significantly since 2024, when the FDA approved the use of pembrolizumab (brand name Keytruda) with chemoradiation for stage 3-4A disease.

Roswell Park Comprehensive Cancer Center

February 25, 2026

Insights on Sarcomas, Gastroesophageal Cancers, Peritoneal Tumors Anchor Roswell Park Presentations at SSO 2026

A Roswell Park study is shedding light on the little-understood dynamics of the tumor microenvironment (TME) in two types of rare and aggressive sarcomas — dedifferentiated liposarcomas (DDLPS) and leiomyosarcomas (LMS). 

Roswell Park Comprehensive Cancer Center

February 25, 2026

Gemcitabine Intravesical System Shows High Disease-Free Survival Rates in BCG-Unresponsive Papillary-Only NMIBC

Monotherapy with a gemcitabine intravesical system demonstrated high disease-free survival rates in patients with bacillus Calmette-Guérin-unresponsive papillary-only high-risk non–muscle-invasive bla...

The ASCO Post

February 24, 2026

Single-Port Robotic Surgery Now Helps Head and Neck Surgeons Treat Hard-to-Reach Tumors

A Keck Medicine of USC head and neck surgeon explains the advantages — as well as remaining challenges.

Keck Medicine of USC